Sarink, Danja
Schock, Helena
Johnson, Theron
Chang-Claude, Jenny
Overvad, Kim
Olsen, Anja
Tjønneland, Anne
Arveux, Patrick
Fournier, Agnès
Kvaskoff, Marina
Boeing, Heiner
Karakatsani, Anna
Trichopoulou, Antonia
La Vecchia, Carlo
Masala, Giovanna
Agnoli, Claudia
Panico, Salvatore
Tumino, Rosario
Sacerdote, Carlotta
van Gils, Carla H.
Peeters, Petra H. M.
Weiderpass, Elisabete
Agudo, Antonio
Rodríguez-Barranco, Miguel
Huerta, José María
Ardanaz, Eva
Gil, Leire
Kaw, Kay Tee
Schmidt, Julie A.
Dossus, Laure
His, Mathilde
Aune, Dagfinn
Riboli, Elio
Kaaks, Rudolf
Fortner, Renée T. http://orcid.org/0000-0002-1426-8505
Funding for this research was provided by:
Deutsche Krebshilfe (111454)
FP7 People: Marie-Curie Actions (MC-IIF-623984)
European Research Council (2009-AdG 232997)
Health research fund (PI13/00061, PI13/01162)
Cancer Research UK (14136, C570/A16491, C8221/A19170)
Medical Research Council (1000143, MR/M012190)
Article History
Received: 7 March 2018
Accepted: 2 October 2018
First Online: 22 October 2018
Ethics approval and consent to participate
: This project was approved by the International Agency for Research on Cancer (IARC) Ethics Committee (Project No. 12–42) and the University of Heidelberg Ethics Commission (Project No. S311/2014). The EPIC study protocol was approved by the ethical committees of IARC and the participating centers. All participants provided informed consent.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.